We investigated the long-term effect of botulinum toxin type A (BTA) o
n impairment as well as functional health in terms of disability, hand
icap, and quality of life in 64 patients with cervical dystonia. These
patients, who first participated in a double-blind trial, were follow
ed for another 12 months. Fifty-four patients continued treatment afte
r 12 months of follow-up and showed improvement on all scales. Further
more, this effectiveness appeared to increase during follow-up, which
suggests a cumulative clinical effect of BTA.